Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • May 8, 2015
    FDA Planning Public Hearing on Off-label Communication Sometime This Summer
  • May 8, 2015
    APLB Issues Rare Untitled Letter Over Promotional Video for Flublok
  • May 7, 2015
    FDA Yanks Four Promotional Draft Guidances, Including One on Help-seeking, Reminder Ads
  • Apr 30, 2015
    OPDP Untitled Letter Cites Otsuka Over Claims in Promotional Pamphlet
  • Apr 23, 2015
    FDA Draft Guidance Details Standards for Submitting Promotions Electronically
  • Apr 14, 2015
    Two Former Acclarent Executives Indicted Over Alleged Off-label Promotion Conspiracy
  • Apr 7, 2015
    Letter Pushes OPDP To Take Action Against Diabetes Ads Making Weight Loss Claims
  • Apr 6, 2015
    FDA Seeks OMB Approval for Study of Price Comparisons in Ads
  • Mar 26, 2015
    Appeals Court: Mandatory Disclosures Do Not Authorize Promotional Claims
  • Mar 19, 2015
    GSK, McNeil Settle False Advertising Suit Concerning OTC Allergy Drug
  • More

Good Clinical Practice

  • Jul 28, 2016
    FDA Softens Device Adaptive Design Guidance
  • Jul 25, 2016
    HHS OIG Still Finds Problems with FDA’s Monitoring of Required Postmarket Studies
  • Jul 23, 2016
    EMA Releases Concept Paper as First Step in Revising ‘First-in-Human’ Trial Guidelines
  • Jul 23, 2016
    Informatics Experts Caution FDA on Use of EHR for Clinical Research
  • Jul 22, 2016
    ACRP Offers Free Online Introductory Clinical Trials Training
  • Jul 21, 2016
    Researchers Say Behavioral ‘Nudges’ Could Improve Trial Recruitment
  • Jul 16, 2016
    Device Companies and Owner Will Pay $4.5 Million for NIH Grant Fraud
  • Jul 14, 2016
    Expanded Access Is Important, But Getting Products Approved Is the Best Way To Get Drugs To People
  • Jul 13, 2016
    ACP Supports National Academies’ Call To Halt Common Rule Revision
  • Jul 11, 2016
    NIH Trial Innovation Network Gets Going
  • More

FDA Regulation & Enforcement

  • Mar 12, 2019
    NCI Director Sharpless To Serve as Acting FDA Commissioner Following Gottlieb’s Departure
  • Mar 12, 2019
    Pa. House Considers Bill Mandating Drug Cost Reporting
  • Mar 11, 2019
    OPDP Moves Forward with HCP Survey
  • Mar 6, 2019
    FDA Warns Canadian Rx Service Provider for Supplying Unapproved Drugs Through Employer Health Plans
  • Mar 6, 2019
    FDA Issues Warning Letter for Marketing Laser as Sole Screening Device for Breast Cancer
  • Mar 5, 2019
    Gottlieb Resigns as FDA Commissioner
  • Mar 5, 2019
    Survey Finds Few Patients Looking Up Doctors on Open Payment Database
  • Mar 5, 2019
    FDA Issues First Warning Letter Alleging Violations of the Drug Supply Chain Security Act Mandates
  • Mar 5, 2019
    N.Z. Survey Finds Adults with Unhealthier Lifestyles More Responsive to DTC Ads
  • Mar 5, 2019
    Survey Finds Public Support for Listing Prices in Drug Ads
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.